These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3431058)

  • 21. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of a new anti-ulcer agent].
    Sansoni P
    Clin Ter; 1979 Mar; 88(5):473-9. PubMed ID: 466969
    [No Abstract]   [Full Text] [Related]  

  • 28. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
    Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
    Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of ulcer disease with L-dopa].
    Zavodskaia IS; Sibirkin NV; Egorova GI; Zabrodin ON
    Ter Arkh; 1976; 48(5):79-82. PubMed ID: 948803
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
    Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The new possibilities for improving peptic ulcer therapy with the use of probiotic drugs].
    Iarovenko II; Golofeevskiĭ VIu; Sitkin SI
    Voen Med Zh; 2007 Mar; 328(3):17-22. PubMed ID: 17580472
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modern drugs used in the treatment of peptic ulcer].
    Ignat'ev MV
    Med Sestra; 1988 May; 47(5):41-6. PubMed ID: 3412153
    [No Abstract]   [Full Text] [Related]  

  • 33. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of duodenal peptic ulcer by the transduodenal administration of drugs via a fiberendoscope].
    Bondarenko VP; Obukhovskiĭ IA; Tikhonova VP; Golubiani DG
    Sov Med; 1982; (7):96-8. PubMed ID: 7135064
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
    Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

  • 37. [Modified triple therapy: what degree of acid inhibition is necessary?].
    Müller P; Simon B
    Leber Magen Darm; 1996 May; 26(3):171-3. PubMed ID: 8709832
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ulcer-healing effect of alanton].
    Luchkova MM
    Ter Arkh; 1978; 50(1):37-8. PubMed ID: 635794
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [National surveillance of Helicobacter pylori eradication in Denmark. Results based on registration of 34.582 drug prescriptions].
    Juul KV; Thomsen OO; Nissen A; Hallas J; Kolmos HJ; Funch-Jensen PM; Lauritsen K
    Ugeskr Laeger; 1999 Nov; 161(48):6635-8. PubMed ID: 10643349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.